Liver Elastography in Suspected Liver Disease

Primary Role and Clinical Applications

The American Gastroenterological Association (AGA) suggests that elastography serves as a noninvasive alternative to liver biopsy for staging fibrosis and diagnosing cirrhosis, with the highest accuracy for detecting advanced disease, demonstrating sensitivity of 89% and specificity of 91% for diagnosing cirrhosis across multiple liver disease etiologies 1
Elastography shows 70% sensitivity and 84% specificity for detecting significant fibrosis (≥F2 stage), which determines treatment need in many conditions 1

For viral hepatitis (hepatitis C and B), proceed directly to elastography without preliminary screening tests, and use >7.0 kPa cutoff for significant fibrosis (≥F2) and >12.5 kPa cutoff for cirrhosis diagnosis, supported by high-quality evidence 1, 2, 3
For alcoholic liver disease, perform elastography immediately if the patient drinks at harmful levels, and apply 12.5 kPa cutoff to diagnose cirrhosis, which yields 95% sensitivity and 71% specificity 1, 2, 3
For non-alcoholic fatty liver disease (NAFLD), calculate FIB-4 score first using routine labs, and if FIB-4 suggests risk, then proceed to elastography, using <8.0 kPa cutoff to rule out advanced fibrosis 1, 2, 3

Vibration-controlled transient elastography (VCTE/FibroScan) should be the first-line method, as it is the most validated, can be performed at bedside, is rapid, and has acceptable reproducibility 1, 4
Switch to magnetic resonance elastography (MRE) when BMI >30 kg/m² and VCTE results are unreliable or fail, or when more precise staging is needed 1, 5

Check ALT levels before interpreting results, as elevated ALT >80 IU/L causes falsely elevated stiffness measurements in the cirrhosis range despite minimal actual fibrosis 1
Ensure proper fasting status, as non-fasting studies are unreliable and artificially elevate measurements 1

Values <6.8 kPa indicate low risk for cirrhosis and its complications, requiring only routine monitoring with lifestyle modification and repeat testing in 2-3 years if risk factors persist 5, 6
Values 7.0-12.5 kPa suggest significant fibrosis, requiring closer monitoring, treatment consideration for viral hepatitis, and aggressive risk factor modification 1
Values >12.5 kPa indicate probable cirrhosis, and mandate screening for varices, hepatocellular carcinoma surveillance, and specialist referral 1, 2, 3

Always correlate elastography with serum fibrosis scores to increase diagnostic confidence, using FIB-4, NAFLD Fibrosis Score, and APRI score 1, 2, 3, 6
When results are discordant or uncertain, liver biopsy remains necessary for definitive staging, particularly in NAFLD where elastography evidence is weakest 2, 3